223 related articles for article (PubMed ID: 16181461)
1. Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours.
Hinterhuber G; Cauza K; Dingelmaier-Hovorka R; Diem E; Horvat R; Wolff K; Foedinger D
Br J Dermatol; 2005 Oct; 153(4):785-9. PubMed ID: 16181461
[TBL] [Abstract][Full Text] [Related]
2. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
3. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma.
Dang C; Gottschling M; Roewert J; Forschner T; Stockfleth E; Nindl I
Br J Dermatol; 2006 Oct; 155(4):763-70. PubMed ID: 16965426
[TBL] [Abstract][Full Text] [Related]
4. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
[TBL] [Abstract][Full Text] [Related]
5. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
Zhang X; Egawa K; Xie Y; Ihn H
Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
[TBL] [Abstract][Full Text] [Related]
7. RPE65 of retinal pigment epithelium, a putative receptor molecule for plasma retinol-binding protein, is expressed in human keratinocytes.
Hinterhuber G; Cauza K; Brugger K; Dingelmaier-Hovorka R; Horvat R; Wolff K; Foedinger D
J Invest Dermatol; 2004 Feb; 122(2):406-13. PubMed ID: 15009723
[TBL] [Abstract][Full Text] [Related]
8. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor expression in non-melanoma skin cancer.
Basile J; Thiers B; Maize J; Lathers DM
J Cutan Pathol; 2008 Jul; 35(7):623-9. PubMed ID: 18312436
[TBL] [Abstract][Full Text] [Related]
10. BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours.
Bock VL; Lyons JG; Huang XX; Jones AM; McDonald LA; Scolyer RA; Moloney FJ; Barnetson RS; Halliday GM
Br J Dermatol; 2011 Jun; 164(6):1221-7. PubMed ID: 21564052
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 105 is overexpressed in squamous cell carcinoma and extramammary Paget disease but not in basal cell carcinoma.
Muchemwa FC; Nakatsura T; Ihn H; Kageshita T
Br J Dermatol; 2006 Sep; 155(3):582-5. PubMed ID: 16911285
[TBL] [Abstract][Full Text] [Related]
12. Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma.
Huang K; Huang C; Shan K; Chen J; Li H
Clin Exp Dermatol; 2012 Jun; 37(4):411-7. PubMed ID: 22420613
[TBL] [Abstract][Full Text] [Related]
13. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
14. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
16. Expression of RUNX3 in skin cancers.
Lee JH; Pyon JK; Kim DW; Lee SH; Nam HS; Kang SG; Kim CH; Lee YJ; Chun JS; Cho MK
Clin Exp Dermatol; 2011 Oct; 36(7):769-74. PubMed ID: 21623876
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid receptor isoform mRNA expression differs between BCC and SCC of the skin.
Hartmann F; Kosmidis M; Mühleisen B; French LE; Hofbauer GF
Arch Dermatol; 2010 Jun; 146(6):675-6. PubMed ID: 20566936
[No Abstract] [Full Text] [Related]
18. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
19. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.
Zaravinos A; Kanellou P; Spandidos DA
Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697
[TBL] [Abstract][Full Text] [Related]
20. Expression of the peripheral benzodiazepine receptor is decreased in skin cancers in comparison with normal skin.
Morgan J; Oseroff AR; Cheney RT
Br J Dermatol; 2004 Oct; 151(4):846-56. PubMed ID: 15491426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
